Pancreatic
BNT327-09
A Phase II, multi-site, randomized, open-label, trial of BNT327 in combination with chemotherapy in patients with metastatic pancreatic cancer.
Trial overview
Clinical Area
Medical Oncology
Disease
Pancreatic
Disease site
Gastrointestinal (GI)
Study Phase
II
Trial Identifiers
Registration number: NCT07255404
GenesisCare Location(s)
Principal Investigator(s)